baber/WOPTO huggingface dataset:
Patent DE-69405448-D1 (DE)
Inventor: SIMEONE GIOVANNI
IPC: C08F20/24
Filed: 1994-04-25
Granted: 1997-10-16
Abstract: Coatings based on perfluoropolyethers terminated with acrylic groups and containing ethoxylic groups as a connecting bridge between the fluorinated part and the (meth)acrylic group.
Patent DE-69414720-D1 (DE)
Inventor: FU ROGER
IPC: C07D407/00
Filed: 1994-09-12
Granted: 1998-12-24
Abstract: The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.
Patent DE-69415690-D1 (DE)
Inventor: DELUCA HECTOR
IPC: A61P43/00
Filed: 1994-10-19
Granted: 1999-02-11
Abstract: The invention is drawn to 17-formyl vitamin D compounds having the following formula   <IMAGE>   The compounds are intermediates in the production of 5,6-trans-(E)-20(22)-Dehydrovitamin D compounds which are useful for the treatment of diseases where bone formation is desired, such as osteoporosis, and for the treatment of diseases characterized by abnormal cell differentiation or cell proliferation, such as psoriasis.
Patent DE-69424677-D1 (DE)
Inventor: OKUYAMA SHIGERU
IPC: A61K31/135
Filed: 1994-09-06
Granted: 2000-06-29
Abstract: Provision of a drug for curing drug dependence which is less toxic and highly effective. A therapeutic composition for drug dependence which comprises as an active ingredient a phenylalkylamine derivative represented by the formula: <CHEM> (wherein X<1> is a halogen atom, a hydroxyl group or an alkoxy group having 1 to 5 carbon atoms, X<2> is a hydrogen atom, a halogen atom or an alkoxy group having 1 to 5 carbon atoms, each of R<1> and R<2> is an alkyl group having 1 to 7 carbon atoms, R<3> is a phenyl group or a substituted phenyl group having as the substituent a halogen atom, a hydroxyl group or an alkoxy group having 1 to 5 carbon atoms, and each of m and n is an integer of 2 to 5) or a pharmaceutically acceptable salt thereof.
Patent DE-69425271-D1 (DE)
Inventor: CAMPFIELD RICHARD A
IPC: B32B17/10
Filed: 1994-11-14
Granted: 2000-08-17
Abstract: The present invention provides a kit for assembly of glass repair tools comprising;     a first bar (40) and a second bar (60); means (120) for connecting the bars substantially at a right angle to each other, a resin injector (152) attachable to a first end of the first bar in such a way as it can adjusted to project to a greater or lesser from the first bar, a pair of suction cups (70) that are attachable to respective ends of the second bar (60) or to the middle of the first bar (40); and a pressure bolt (130) attachable either to a second end of the first bar (40) or to the middle of the second bar (60) in such a way as it can adjusted to project to a greater or lesser from the bar concerned,  whereby the following tools may be assembled:   (1) a repair bridge (Figs 2 and 3) in which said first and second bars (40,60) are attached at their middles, the resin injector (152) and the pressure bolt are adjustably attached at opposite ends of the first bar (40) and suction cups (70) are attached at opposite ends of the second bar (60); (2) a crack opener in which the suction cups (70) are attached to opposite ends of the second bar (60) and the pressure bolt (130) is adjustably attached to the middle of the second bar and (3) a repair bar tool in which the resin injector (152) and the pressure bolt (130) are adjustably attached to opposite ends of the first bar (40) and a suction cup (70) is attached to the middle of the first bar.   <IMAGE>   <IMAGE>
Patent DE-69430232-D1 (DE)
Inventor: FONTANA STEVEN ANTHONY
IPC: A61P25/00
Filed: 1994-12-19
Granted: 2002-05-02
Abstract: The use of 2-phenyl-3-benzoylbenzothiophenes of formula (I) and their salts to inhibit the symptoms of premenstrual syndrome (PMS) or late luteal phase dysphoric disorder (LLPDD) is new. R1, R3 = H, Me, C(O)(1-6C)alkyl or CO-Ar; Ar = opt. substd. phenyl; R2 = pyrrolidine, hexamethyleneimino or piperidino.
Patent DE-69430489-D1 (DE)
Inventor: PAQUET N
IPC: C08J9/12
Filed: 1994-09-16
Granted: 2002-05-29
Abstract: Disclosed is a foam structure of desirable mechanical strenght made with a low molecular weight alkenyl aromatic polymer material and an inorganic blowing agent. The polymer material has an alkenyl aromatic polymer of a weight average molecular weight of 100,000 to 165,000. The foam structure can be made in processes with reduced pressure drop.
Patent DE-69501866-D1 (DE)
Inventor: HOFMANN ARMIN
IPC: B65G47/51
Filed: 1995-05-02
Granted: 1998-04-30
Abstract: PCT No. PCT/CH95/00098 Sec. 371 Date Feb. 9, 1996 Sec. 102(e) Date Feb. 9, 1996 PCT Filed May 2, 1995 PCT Pub. No. WO95/29863 PCT Pub. Date Nov. 9, 1995A suspended storage apparatus in which products (16) are placed in trays (14) supporting shelves (15) for carrying the products. The receiving station of the apparatus comprises an assembly consisting of a pushing device connected to a first drive mechanism (101A), the pushing device including at least one substantially horizontally movable pushing member (107) for transferring products from the shelves to a conveyor belt (108), and a second drive mechanism (101B) for moving the pushing member substantially vertically as it moves horizontally. This combination of two directions of motion enables continuous discharge of the products.
Patent DE-69504309-D1 (DE)
Inventor: SPOEL HAN
IPC: C22B7/00
Filed: 1995-02-10
Granted: 1998-10-01
Abstract: A process and apparatus are disclosed for recovering a non-ferrous metal, preferably aluminum and aluminum alloys, in molten coherent form from a charge of material to be processed containing the metal. The charge is introduced into a sealable furnace which is then sealed. The charge is agitated. A control parameter indicative of conditions inside said furnace is monitored and compared to a pre-determined first condition for the parameter. A heat source is operated to heat the charge until the control parameter reaches the first condition. The operation of the heat source is then stopped. A controlled amount of oxidizing agent and an inert carrier is then introduced into the furnace. The control parameter is monitored and compared to a predetermined second condition for the parameter. The flow of the oxidizing agent and the carrier is controlled to maintain the control parameter at about the second condition. The molten metal is subsequently removed from the furnace.
Patent DE-69514819-D1 (DE)
Inventor: SASAKI MASANORI
IPC: B65B3/00
Filed: 1995-09-26
Granted: 2000-03-02
Abstract: A liquid charging nozzle plate (10) comprising a plate body provided with a plurality of through holes (11). This liquid charging nozzle plate (10) is used by fixing the same to a lower end opening of a liquid charging tube (67). The outflow of a liquid with which the liquid charging tube (67) is filled is prevented owing to the surface tension of the liquid in the through holes (11) of the liquid charging nozzle plate (10). On an inner circumferential surface (13) of each through hole (11), projections (15) are provided which extend in the circumferential direction so that the inner diameter of the through hole (11) decreases. Owing to the cross-sectional shape of this through hole (11), the dripping of the liquid from the through hole (11) can be prevented effectively. Even when the through holes (51) are formed cross-sectionally to an elongated slit-like shape, the dripping of a liquid therefrom can also be prevented effectively.   <IMAGE>
Patent DE-69519201-D1 (DE)
Inventor: HUGUENIN DENIS
IPC: C09K11/78
Filed: 1995-06-23
Granted: 2000-11-30
Abstract: The use of doped tantalite of yttrium, lutetium or gadolinium in the form of luminophores is for the mfr. of devices with a high voltage luminescence. The tantalite used may be doped with niobium or a rare earth chosen esp. from praseodymium, europium, terbium and thulium. The high voltage luminescence device produced is also claimed.
Patent DE-69519429-D1 (DE)
Inventor: BEAN COLIN
IPC: A61L2/26
Filed: 1995-05-12
Granted: 2000-12-21
Abstract: A container for enabling fluid flow therethrough for cleaning or sterilising of the contents, comprises a tray (10) and lid (20) and having respective bases (11, 21) and side walls (17, 27). The bases (11, 21) have perforations (12, 22) defined by elliptically shaped perforation walls (13, 23) with their major axes vertical to allow easy flow of the cleaning fluid through the container and minimum contact points with the contents or other containers.
Patent DE-69526278-D1 (DE)
Inventor: BERNDT KLAUS W
IPC: G01N33/487
Filed: 1995-01-26
Granted: 2002-05-16
Abstract: A method of analyzing the data provided by a fluorescent chemical sensor calculates a ratio based on the AC and DC components of the emission from the chemical sensor. This ratio, or the emission modulation, will change should bacterial growth be ongoing in the vial. The calculated ratio is compared to a desired value. The desired value is selected to focus the operation of the system into a high resolution area for the sensor. If the calculated and desired ratios differ, then the frequency of the excitation radiation is changed until the calculated and desired ratios are effectively equal. At that time the adjusted frequency is measured. By focusing the desired ratio into a high resolution area, and adjusting the frequency until the system reaches that ratio one ensures that all readings are performed at a high resolution area of the sensor. The adjusted frequency is utilized to provide an indication of whether the particular vial is experiencing bacterial growth. This adjusted frequency is a linear function of changing conditions within the vial. Several methods of achieving the above features of this invention are disclosed. By utilizing this method, one provides an easily interpreted indication of whether a particular fluorescent chemical sensor is in a vial which is experiencing bacterial growth. <IMAGE>
Patent DE-69531889-D1 (DE)
Inventor: JOHNSON WILLIAM TERRY
IPC: C07K14/605
Filed: 1995-08-25
Granted: 2003-11-13
Abstract: N-terminal truncated forms of glucagon like insulinotropic peptide (GLP-1) and analogs thereof are provided. The claimed polypeptides promote glucose uptake by cells but do not stimulate insulin expression or secretion. The invention also provides methods for treating diabetes and pharmaceutical formulations comprising the claimed polypeptides.
Patent DE-69532680-D1 (DE)
Inventor: POLYPIPE PLC EDLINGTON
IPC: E03D1/34
Filed: 1995-10-23
Granted: 2004-04-15
Abstract: PCT No. PCT/GB95/02493 Sec. 371 Date Aug. 8, 1997 Sec. 102(e) Date Aug. 8, 1997 PCT Filed Oct. 23, 1995 PCT Pub. No. WO96/14479 PCT Pub. Date May 17, 1996An improved discharge valve comprises an upper housing, an upwardly movable main valve assembly within the housing and forming with the upper part thereof a variable volume upper chamber, a restricted passage between the upper chamber and the exterior thereof, an outlet leading down from the lower part of the housing, a seat for the main valve assembly at the entry to the outlet so that, in the lowered position of the main valve assembly, the outlet is blocked against ingress of fluid in which the device is immersed, and a pilot stem actuable remotely from the housing to put the upper chamber in free communication with the outlet. The arrangement being such that, once such free communication is established, fluid escapes the upper chamber and the change in relative pressures above and below the main valve assembly causes the latter to unseat thereby permitting flow of the immersing fluid into the outlet and its substantially complete discharge. The cessation of flow of the immersing fluid allows the main valve assembly to revert to its seated position with the pilot stem cutting off free communication, and air penetrates the upper chamber and on replenishment of immersing fluid, a net downward pressure is created on the main valve assembly to keep it seated. The pilot valve has a hollow stem communicating to atmosphere above the normal full set level of fluid in the cistern. The main valve assembly and the hollow stem define therebetween a hollow annulus.
Patent DE-69535604-D1 (DE)
Title: Transgenes fibrinogen
Inventor: VELANDER WILLIAM H
IPC: A01K67/027
Filed: 1995-02-17
Granted: 2007-11-15
Abstract: Transgenic non-human animals, capable of expressing a heterologous gene for human or other recombinant fibrinogen protein or subunit chain polypeptides thereof or modified fibrinogens in mammary glands of the animals and secreting the expressed product into a body fluid, are provided, as are methods of producing recombinant fibrinogens, subunit chains polypeptides thereof and modified fibrinogens, and fibrinogens fusion proteins in such animals.
Patent DE-69607763-D1 (DE)
Inventor: LOCATELLI ACHILLE
IPC: D04H13/00
Filed: 1996-11-11
Granted: 2000-05-18
Abstract: PCT No. PCT/EP96/05006 Sec. 371 Date May 18, 1998 Sec. 102(e) Date May 18, 1998 PCT Filed Nov. 11, 1996 PCT Pub. No. WO97/18364 PCT Pub. Date May 22, 1997A synthetic textile support for bituminous sheaths, particularly for the coating of roofs. The textile support consists of two layers of non-woven lap of polyester fibers, between which there is interposed a plurality of continuous polyester threads arranged parallel to one another in the longitudinal direction of the textile support.
Patent DE-69608467-D1 (DE)
Inventor: NOORDAM DOMINICUS
IPC: H01J31/50
Filed: 1996-02-21
Granted: 2000-06-21
Abstract: PCT No. PCT/NL96/00081 Sec. 371 Date Oct. 20, 1997 Sec. 102(e) Date Oct. 20, 1997 PCT Filed Apr. 21, 1996 PCT Pub. No. WO96/33508 PCT Pub. Date Oct. 24, 1996Streak camera whereof the pulse converter for converting a photon pulse for detecting into an electron stream comprises a gaseous medium. A streak camera for a photon pulse in the far-infrared region is provided with a laser source to bring particles in the medium into a Rydberg state, in a streak camera for an X-ray pulse the medium contains particles for bringing into an Auger state, and additional deflection plates are provided for separating a primary electron stream from a secondary electron stream.
Patent DE-69614564-D1 (DE)
Inventor: COLLINS ELIZABETH
IPC: B01D15/00
Filed: 1996-12-02
Granted: 2001-09-20
Abstract: A process for the reversed phase chromatographic decalorisation, separation and purification of water-soluble nonionic contrast media compounds from solutions containing nonionic compound impurities is described. A solution containing the contrast media compound and impurities is passed through a chromatographic column the column is eluted to produce primary eluate, and a solvent is passed through the column. The solvent is removed from the mixture thus formed leaving an aqueous solution which concentrated and nonionic constrast media compound is recovered from the aqueous solution.
Patent DE-69634079-D1 (DE)
Inventor: FERRARA NAPOLEONE
IPC: C07K16/22
Filed: 1996-03-28
Granted: 2005-01-27
Abstract: The present invention provides human vascular endothelial cell growth factor (hVEGF) antagonists, including monoclonal antibodies, hVEGF receptors, and hVEGF variants that are useful for the treatment of age-related macular degeneration, as well as other diseases and disorders characterized by undesirable or excessive neovascularization.
Patent DE-69634782-D1 (DE)
Inventor: STROBER WARREN
IPC: C12N15/24
Filed: 1996-03-29
Granted: 2005-06-30
Abstract: The present invention provides a method for treating the inflammatory response of an established colitis in a subject with inflammatory bowel disease (IBD), comprising administering to a subject diagnosed with an established colitis from an IBD an amount of an antibody to interleukin-12 effective in reducing the colitis-inducing effect of interleukin-12. Also provided is a method for screening a substance for its effectiveness in reducing the inflammatory response of an established colitis comprising obtaining an animal having an established colitis; administering the substance to an animal; and assaying the animal for an effect on interleukin-12 which results in the reduction of the inflammatory response of the colitis, an amount of reduction of the inflammatory response greater than the amount of reduction produced by the administration of antibodies against interferon-gamma or tumor necrosis factor-alpha indicating an effective substance. Additionally, the present invention provides a method for screening a substance for its effectiveness in preventing inflammatory bowel disease comprising administering the substance to an animal susceptible to colitis; subjecting the animal to a treatment that will induce a colitis; assaying the animal for the development of a colitis; and comparing the effectiveness of the substance in preventing development of a colitis to the effectiveness of antibodies to interferon-gamma or tumor necrosis factor-alpha in preventing development of a colitis, a substance more effective in preventing the development of a colitis than antibodies to interferon-gamma or tumor necrosis factor-alpha indicating an effective substance.
Patent DE-69702399-D1 (DE)
Inventor: THEVENOT BENOIT
IPC: G06K19/077
Filed: 1997-07-31
Granted: 2000-08-03
Abstract: An integrated circuit card with two connection modes. The integrated circuit card includes a card body in which there is embedded a link circuit for linking a contactless coupling element (1) to a module having an integrated circuit (6) connected to conductive areas carried by a support film (4). The link circuit extends in register with conductive areas (18) dedicated to making a contactless link and is connected to said conductive areas by an electrically conductive material (32, 36, 42) filling blind holes (31, 35, 41). The blind holes have sections that increase from a bottom of each hole towards an opening thereof over at least a portion of their height.
Patent DE-69704946-D1 (DE)
Inventor: NIXON ALISTAIR
IPC: C08F2/06
Filed: 1997-07-28
Granted: 2001-06-28
Abstract: A curable acrylic polymer composition useful in coating, sealant or adhesive compositions comprises an acrylic polymer containing pendant functional groups selected from epoxide groups, isocyanate groups, alkoxysilane groups and activated -CH- groups bonded to at least two electron-withdrawing groups and a curing agent which is reactive with the functional groups of the acrylic polymer and is characterized in that the polymer is dissolved in an organic compound of viscosity less than 2 Pas (20 poise) at 25° C. containing at least one functional group of the same functionality as that present in the acrylic polymer. The composition can be prepared by the free radical polymerization of a functional olefinically unsaturated monomer, and optionally one or more ethylenically unsaturated comonomers, in the presence of the said functional organic compound as diluent.
Patent DE-69706407-D1 (DE)
Inventor: CHANDRAKUMAR NIZAL
IPC: C07C275/42
Filed: 1997-03-26
Granted: 2001-10-04
Abstract: The present invention relates to a class of compounds represented by the Formula I   <IMAGE>   or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the  alpha v beta 3 integrin.
Patent DE-69709272-D1 (DE)
Inventor: PASCAL YVES
IPC: A61P19/02
Filed: 1997-03-27
Granted: 2002-01-31
Abstract: Diazepino indoles of formula (I), their racemic and isomeric forms, and their salts are new. A = aryl or nitrogen heteroaryl (both optionally substituted by 1-3 of halo, lower alkyl, haloalkyl, lower alkoxy, cycloalkoxy, amino, lower alkoxy- or alkyl-carbonylamino); B = OR1, NR2R3, NR2aR3a, NHR2', or NHR2''; R1 = H or R4; R2' = C(NH)NH2; R2'' = R4; R2a, R3a = H or lower alkyl; NR2R3 = 5-7 membered saturated heterocycle optionally containing O, N, or S not attached directly to the first N; R4 = CH2COOH, CO(CH2)pCOOH, COA, COCH=CHCOOH, CO(CH2)nCH3, CO(CH2OCH2)pCH2OCH3, CO(CH2OCH2)pCOOH or (CH2)pNR5aR6a or (CH2)pNR5R6; NR5R6 = as NR2R3; R5a, R6a = as R2a, R3a; n = 0-18; and p = 2-4. Also claimed are intermediates of formula (II).
Patent DE-69712893-D1 (DE)
Inventor: AITKEN WILLIAM RUSSELL SCOTT
IPC: E21B17/22
Filed: 1997-08-20
Granted: 2002-07-04
Abstract: A drill pipe having a length of conduit having a first diameter, a first and a second end portion, where each end portion has a second diameter greater than the first diameter. An enlarged portion is located between and spaced from the first and second end portions, where the enlarged portion comprises a central section which has a third diameter greater than the first diameter. The central section has a substantially smooth external surface, and two end sections, one end section at either end of the central section, which vary in diameter between the first and the third diameter. One of the end sections has a spiral formation thereon.
Patent DE-69715151-D1 (DE)
Inventor: EYAL AHARON
IPC: C07C57/00
Filed: 1997-01-21
Granted: 2002-10-10
Abstract: PCT No. PCT/GB97/00176 Sec. 371 Date Oct. 13, 1998 Sec. 102(e) Date Oct. 13, 1998 PCT Filed Jan. 21, 1997 PCT Pub. No. WO97/27312 PCT Pub. Date Jul. 31, 1997The invention provides a process for the preparation of aspartic acid via a fermentation process for the preparation of ammonium fumarate, wherein the pH of the fermentation broth is controlled by the addition of a calcium base to produce a calcium fumarate precipitate, characterized in that ammonium fumarate is produced by separating the precipitated calcium fumarate from the fermentation broth, and reacting the same with a reagent selected from ammonia, ammonium carbonate, ammonia in combination with CO2 and mixtures thereof, to form ammonium fumarate and a co-product selected from calcium carbonate and calcium hydroxide, wherein the energy of indirect neutralization of fumaric acid by ammonia serves as the driving force for the conversion of calcium fumarate to the desired ammonium fumarate product and for the regeneration of a calcium base reagent, and wherein diammonium fumarate is enzymatically converted to ammonium aspartate and acidulated to from aspartic acid.
Patent DE-69719031-D1 (DE)
Inventor: SULLIVAN J
IPC: A61Q11/00
Filed: 1997-05-23
Granted: 2003-03-20
Abstract: A dual component dentifrice composition in which the first component is a stable, semi-solid, extrudable dentifrice composition containing a fluoride ion releasable compound in which calcium ion is absent and the second component is a semi-solid, extrudable dentifrice composition containing a dicalcium phosphate abrasive having a magnesium ion content less than about 0.5% by weight wherein increased fluoride uptake is achieved when the components are mixed upon application to dental tissue.
Patent DE-69733759-D1 (DE)
Inventor: LEBEL EDOUARD GUILLAUME
IPC: C12N15/09
Filed: 1997-09-12
Granted: 2005-08-25
Abstract: The instant disclosure describes the application of genetic engineering techniques to produce cellulase in plants. Cellulase coding sequences operably linked to promoters active in plants may be transformed into the nuclear genome and/or the plastid genome of a plant. As cellulases may be toxic to plants, chemically-inducible or wound-inducible promoters may be employed. Additionally, the expressed cellulases may be targeted to vacuoles or other cellular organelles.